MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 224 filers reported holding MYRIAD GENETICS INC in Q3 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | – | 0 | – | 0.00% | – |
Q4 2020 | $0 | – | 0 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
Q4 2019 | $0 | – | 15 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2018 | $6,000 | -93.8% | 225 | -89.3% | 0.00% | -100.0% |
Q3 2018 | $96,000 | +31.5% | 2,094 | +6.9% | 0.00% | +33.3% |
Q2 2018 | $73,000 | +73.8% | 1,959 | +58.8% | 0.00% | +50.0% |
Q1 2018 | $42,000 | 0.0% | 1,234 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $42,000 | +110.0% | 1,234 | +124.8% | 0.00% | +100.0% |
Q3 2017 | $20,000 | +300.0% | 549 | +175.9% | 0.00% | – |
Q2 2017 | $5,000 | 0.0% | 199 | -17.1% | 0.00% | – |
Q1 2017 | $5,000 | +25.0% | 240 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | -77.8% | 240 | -72.4% | 0.00% | -100.0% |
Q3 2016 | $18,000 | -33.3% | 870 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $27,000 | -22.9% | 870 | +8.8% | 0.00% | 0.0% |
Q4 2015 | $35,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tieton Capital Management, LLC | 160,434 | $4,457,000 | 3.90% |
KESTREL INVESTMENT MANAGEMENT CORP | 231,875 | $6,441,000 | 3.04% |
SG Capital Management LLC | 501,818 | $13,941,000 | 2.21% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,707,364 | $75,211,000 | 1.40% |
Global Alpha Capital Management Ltd. | 269,000 | $7,473,000 | 1.30% |
S&T BANK/PA | 166,772 | $4,633,000 | 1.02% |
MARATHON CAPITAL MANAGEMENT | 79,460 | $2,207,000 | 0.90% |
Taylor Frigon Capital Management LLC | 45,903 | $1,275,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,556,000 | 0.84% |
Millrace Asset Group, Inc. | 29,222 | $812,000 | 0.84% |